Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
HRH2 Biologics Sequence Review Report 2026: Histamine H2 receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of HRH2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
HTR1B Biologics Sequence Review Report 2026: 5-hydroxytryptamine receptor 1B Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of HTR1B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
HTR1A Biologics Sequence Review Report 2026: 5-hydroxytryptamine receptor 1A Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of HTR1A protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GRPR Biologics Sequence Review Report 2026: Gastrin-releasing peptide receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GRPR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
HCAR3 Biologics Sequence Review Report 2026: Hydroxycarboxylic acid receptor 3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of HCAR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GRIK1 Biologics Sequence Review Report 2026: Glutamate receptor ionotropic, kainate 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GRIK1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GRIA4 Biologics Sequence Review Report 2026: Glutamate receptor 4 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GRIA4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GNRHR Biologics Sequence Review Report 2026: Gonadotropin-releasing hormone receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GNRHR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GRIA2 Biologics Sequence Review Report 2026: Glutamate receptor 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GRIA2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GRIA1 Biologics Sequence Review Report 2026: Glutamate receptor 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GRIA1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GRIA3 Biologics Sequence Review Report 2026: Glutamate receptor 3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GRIA3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GLRA3 Biologics Sequence Review Report 2026: Glycine receptor subunit alpha-3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GLRA3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
245
246
247
248
249
>>
1905
>